Key tumor suppressor genes, such as PTEN, and well-known oncogenes, such as Notch and Myc, showed up as major central mutations, and all variants of the most commonly mutated oncogene in human cancers, Ras, were predominant pathway genes (Figure 6A, Supplementary Table S7). This evidence concerns the gene MYC and neoplasm.